{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:03:26Z","timestamp":1752282206430},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:00:00Z","timestamp":1335225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11033-012-1639-3","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T20:39:49Z","timestamp":1335213589000},"page":"7941-7947","source":"Crossref","is-referenced-by-count":5,"title":["Association study of interleukin-4 polymorphisms with paranoid schizophrenia in the Polish population: a critical approach"],"prefix":"10.1007","volume":"39","author":[{"given":"Anna","family":"Fila-Danilow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Kucia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Paul-Samojedny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Borkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Suchanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,24]]},"reference":[{"key":"1639_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","volume":"10","author":"PJ Harrison","year":"2005","unstructured":"Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40\u201368","journal-title":"Mol Psychiatry"},{"key":"1639_CR2","first-page":"2255","volume":"3","author":"M Loh","year":"2007","unstructured":"Loh M, Rolls ET, Deco G (2007) A dynamical systems hypothesis of schizophrenia. PLoS Comput Biol 3:2255\u20132265","journal-title":"PLoS Comput Biol"},{"key":"1639_CR3","first-page":"268","volume":"46","author":"B Avgu\u0161tin","year":"2005","unstructured":"Avgu\u0161tin B, Wraber B, Tav\u010dar R (2005) Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat Med J 46:268\u2013274","journal-title":"Croat Med J"},{"key":"1639_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-1711.2005.01305.x","volume":"83","author":"AL Jones","year":"2005","unstructured":"Jones AL, Mowry BJ, Pender MP et al (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 83:9\u201317","journal-title":"Immunol Cell Biol"},{"key":"1639_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/1744666X.1.1.103","volume":"1","author":"BE Leonard","year":"2005","unstructured":"Leonard BE (2005) Is there an immunologic basis for schizophrenia? Expert Rev Clin Immunol 1:103\u2013112","journal-title":"Expert Rev Clin Immunol"},{"key":"1639_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2006.07.006","volume":"27","author":"RD Strous","year":"2006","unstructured":"Strous RD, Shoenfeld Y (2006) Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27:71\u201380","journal-title":"J Autoimmun"},{"key":"1639_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157339510791823673","volume":"6","author":"N M\u00fcller","year":"2010","unstructured":"M\u00fcller N, Schwarz MJ (2010) Immune system and schizophrenia. Curr Immunol Rev 6:213\u2013220","journal-title":"Curr Immunol Rev"},{"key":"1639_CR8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0278-5846(98)00059-1","volume":"22","author":"CL Cazzullo","year":"1998","unstructured":"Cazzullo CL, Scarone S, Grassi B et al (1998) Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog Neuropsychopharmacol Biol Psychiatry 22:947\u2013957","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1639_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02190280","volume":"246","author":"I Wilke","year":"1996","unstructured":"Wilke I, Arolt V, Rothermundt M et al (1996) Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 246:279\u2013284","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1639_CR10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s004060050067","volume":"249","author":"N M\u00fcller","year":"1999","unstructured":"M\u00fcller N, Riedel M, Ackenheil M et al (1999) The role of immune function in schizophrenia: an overview. Eur Arch Psychiatry Clin Neurosci 249:62\u201368","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1639_CR11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.pnpbp.2004.05.047","volume":"28","author":"YK Kim","year":"2004","unstructured":"Kim YK, Myint AM, Lee BH et al (2004) Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:1129\u20131134","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1639_CR12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaci.2003.08.033","volume":"112","author":"M Kabesch","year":"2003","unstructured":"Kabesch M, Tzotcheva I, Carr D et al (2003) A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 112:893\u2013898","journal-title":"J Allergy Clin Immunol"},{"key":"1639_CR13","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0024-3205(94)90029-9","volume":"54","author":"R Ramchand","year":"1995","unstructured":"Ramchand R, Wei J, Ramchand CN, Hemmings GP (1995) Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment. Life Sci 54:1579\u20131584","journal-title":"Life Sci"},{"key":"1639_CR14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2222.1995.tb00428.x","volume":"25","author":"LJ Rosenwasser","year":"1995","unstructured":"Rosenwasser LJ, Klemm DJ, Dresback JK et al (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25:74\u201378","journal-title":"Clin Exp Allergy"},{"key":"1639_CR15","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1046\/j.1365-2222.2000.00983.x","volume":"30","author":"I Suzuki","year":"2000","unstructured":"Suzuki I, Hizawa N, Yamaguchi E et al (2000) Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels. Clin Exp Allergy 30:1746\u20131749","journal-title":"Clin Exp Allergy"},{"key":"1639_CR16","first-page":"433","volume":"19","author":"AA Amirzargar","year":"2009","unstructured":"Amirzargar AA, Movahedi M, Rezaei N et al (2009) Polymorphisms in IL4 and IL4RA confer susceptibility to asthma. J Investig Allergol Clin Immunol 19:433\u2013438","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1639_CR17","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.159.6.2994","volume":"159","author":"BB Mittleman","year":"1997","unstructured":"Mittleman BB, Castellanos FX, Jacobsen LK et al (1997) Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 159:2994\u20132999","journal-title":"J Immunol"},{"key":"1639_CR18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/schbul\/sbn054","volume":"35","author":"CJ Carter","year":"2008","unstructured":"Carter CJ (2008) Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull 35:1163\u20131182","journal-title":"Schizophr Bull"},{"key":"1639_CR19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ajmg.b.30743","volume":"147B","author":"J Sun","year":"2008","unstructured":"Sun J, Kuo PH, Riley BP et al (2008) Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B 147B:1173\u20131181","journal-title":"Am J Med Genet B"},{"key":"1639_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaci.2004.05.035","volume":"114","author":"MJ Basehore","year":"2004","unstructured":"Basehore MJ, Howard TD, Lange LA et al (2004) A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol 114:80\u201387","journal-title":"J Allergy Clin Immunol"},{"key":"1639_CR21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0165-6147(03)00131-7","volume":"24","author":"K Vandenbroeck","year":"2003","unstructured":"Vandenbroeck K, Goris A (2003) Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends Pharmacol Sci 24:284\u2013289","journal-title":"Trends Pharmacol Sci"},{"key":"1639_CR22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00406-005-0603-9","volume":"256","author":"MJ Schwarz","year":"2006","unstructured":"Schwarz MJ, Kr\u00f6nig H, Riedel M et al (2006) IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 256:72\u201376","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1639_CR23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s100380050176","volume":"44","author":"A Takabayashi","year":"1999","unstructured":"Takabayashi A, Ihara K, Sasaki Y et al (1999) Novel polymorphism in the 5\u2032-untranslated region of the interleukin-4 gene. J Hum Genet 44:352\u2013353","journal-title":"J Hum Genet"},{"key":"1639_CR24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4049\/jimmunol.142.1.274","volume":"142","author":"N Arai","year":"1989","unstructured":"Arai N, Nomura D, Villaret D et al (1989) Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 142:274\u2013282","journal-title":"J Immunol"},{"key":"1639_CR25","volume-title":"Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV)","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams J (1997) Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). American Psychiatric Press, Washington"},{"key":"1639_CR26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"1639_CR27","first-page":"9","volume":"6","author":"S Hosseini-Farahabadi","year":"2007","unstructured":"Hosseini-Farahabadi S, Tavakkol-Afshari J, Rafatpanah H et al (2007) Association between the polymorphisms of IL-4 gene promoter (\u2212590C\u00a0>\u00a0T), IL-13 coding region (R130Q) and IL-16 gene promoter (\u2212295T\u00a0>\u00a0C) and allergic asthma. Iran J Allergy Asthma Immunol 6:9\u201314","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"1639_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(02)00008-3","volume":"323","author":"N Shibata","year":"2002","unstructured":"Shibata N, Ohnuma T, Takahashi T et al (2002) The effect of IL4 +33C\/T polymorphism on risk of Japanese sporadic Alzheimer\u2019s disease. Neurosci Lett 323:161\u2013163","journal-title":"Neurosci Lett"},{"key":"1639_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(00)02398-2","volume":"870","author":"AE Lovett-Racke","year":"2000","unstructured":"Lovett-Racke AE, Smith ME, Arredondo LR et al (2000) Developmentally regulated gene expression of Th2 cytokines in the brain. Brain Res 870:27\u201335","journal-title":"Brain Res"},{"key":"1639_CR30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(00)00404-5","volume":"113","author":"AM Szczepanik","year":"2001","unstructured":"Szczepanik AM, Funes S, Petko W et al (2001) IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113:49\u201362","journal-title":"J Neuroimmunol"},{"key":"1639_CR31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1054\/mehy.1999.0018","volume":"54","author":"NA Munn","year":"2000","unstructured":"Munn NA (2000) Microglia dysfunction in schizophrenia: an integrative theory. Med Hypotheses 54:198\u2013202","journal-title":"Med Hypotheses"},{"key":"1639_CR32","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.cub.2003.11.025","volume":"13","author":"MV Rockman","year":"2003","unstructured":"Rockman MV, Hahn MW, Soranzo N et al (2003) Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr Biol 13:2118\u20132123","journal-title":"Curr Biol"},{"key":"1639_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/1074-7613(95)90027-6","volume":"2","author":"T Hoey","year":"1995","unstructured":"Hoey T, Sun YL, Williamson K et al (1995) Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2:461\u2013472","journal-title":"Immunity"},{"key":"1639_CR34","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00406-008-0813-z","volume":"258","author":"Y Watanabe","year":"2008","unstructured":"Watanabe Y, Nunokawa A, Shibuya M et al (2008) Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population. Eur Arch Psychiatry Clin Neurosci 258:422\u2013427","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1639_CR35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1440-1819.2003.01118.x","volume":"53","author":"TY Jun","year":"2003","unstructured":"Jun TY, Lee KU, Pae CU et al (2003) Polymorphisms of interleukin-4 promoter and receptor gene for schizophrenia in the Korean population. Psychiatry Clin Neurosci 53:283\u2013288","journal-title":"Psychiatry Clin Neurosci"},{"key":"1639_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1744-313X.2005.00524.x","volume":"32","author":"M Kurzawski","year":"2005","unstructured":"Kurzawski M, Pawlik A, Czerny B et al (2005) Frequencies of the common promoter polymorphisms in cytokine genes in a Polish population. Int J Immunogenet 32:285\u2013291","journal-title":"Int J Immunogenet"},{"key":"1639_CR37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1744-313X.2011.01010.x","volume":"38","author":"HJ Park","year":"2011","unstructured":"Park HJ, Kim MJ, Kang SW et al (2011) Association between interleukin-4 gene polymorphisms and intracerebral haemorrhage in Korean population. Int J Immunogenet 38:321\u2013325","journal-title":"Int J Immunogenet"},{"key":"1639_CR38","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v65n0710","volume":"65","author":"XY Zhang","year":"2004","unstructured":"Zhang XY, Zhou DF, Cao LY et al (2004) Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry 65:940\u2013947","journal-title":"J Clin Psychiatry"},{"key":"1639_CR39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","volume":"54","author":"M Maes","year":"2002","unstructured":"Maes M, Bocchio Chiavetto L, Bignotti S et al (2002) Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 54:281\u2013291","journal-title":"Schizophr Res"},{"key":"1639_CR40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.intimp.2005.10.004","volume":"6","author":"CU Pae","year":"2006","unstructured":"Pae CU, Yoon CH, Kim TS et al (2006) Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Int Immunopharmacol 6:666\u2013671","journal-title":"Int Immunopharmacol"},{"key":"1639_CR41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psychres.2007.11.014","volume":"160","author":"SM O\u2019Brien","year":"2008","unstructured":"O\u2019Brien SM, Scully P, Dinan TG (2008) Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res 160:256\u2013262","journal-title":"Psychiatry Res"},{"key":"1639_CR42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0920-9964(00)00046-3","volume":"47","author":"CL Cazzullo","year":"2001","unstructured":"Cazzullo CL, Sacchetti E, Galluzzo A et al (2001) Cytokine profiles in drug-naive schizophrenic patients. Schizophr Res 47:293\u2013298","journal-title":"Schizophr Res"},{"key":"1639_CR43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0278-5846(01)00221-4","volume":"26","author":"CL Cazzullo","year":"2002","unstructured":"Cazzullo CL, Sacchetti E, Galluzzo A et al (2002) Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 26:33\u201339","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1639-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-1639-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1639-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T20:09:03Z","timestamp":1713902943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-1639-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,24]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1639"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-1639-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,24]]}}}